• Consensus Rating: Hold
  • Consensus Price Target: $80.00
  • Forecasted Upside: 117.57%
  • Number of Analysts: 2
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$36.77
▼ -3.18 (-7.96%)

This chart shows the closing price for CTEV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Claritev Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CTEV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CTEV

Analyst Price Target is $80.00
▲ +117.57% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Claritev in the last 3 months. The average price target is $80.00, with a high forecast of $80.00 and a low forecast of $80.00. The average price target represents a 117.57% upside from the last price of $36.77.

This chart shows the closing price for CTEV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 2 investment analysts is to hold stock in Claritev. This rating changed within the last month from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
11/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
11/24/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
11/18/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
11/12/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
11/10/2025CitigroupBoost TargetBuy ➝ Buy$74.00 ➝ $80.00
11/6/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
10/31/2025Weiss RatingsInitiated CoverageSell (D-) ➝ Sell (D-)
1/10/2025CitigroupBoost TargetNeutral ➝ Neutral$10.00 ➝ $12.50
9/23/2024CitigroupLower TargetNeutral ➝ Neutral$17.20 ➝ $10.00
8/7/2024Piper SandlerReiterated RatingNeutral ➝ Neutral$80.00 ➝ $40.00
6/26/2024Piper SandlerInitiated CoverageNeutral$80.00
6/30/2023BarclaysBoost Target$40.00 ➝ $80.00
3/8/2023CitigroupLower TargetNeutral$80.00 ➝ $50.00
1/18/2023BarclaysLower TargetEqual Weight$120.00 ➝ $40.00
12/13/2022CitigroupDowngradeBuy ➝ Neutral$120.00 ➝ $80.00
11/16/2022The Goldman Sachs GroupLower TargetNeutral$220.00 ➝ $82.00
11/9/2022CitigroupLower TargetBuy$240.00 ➝ $120.00
10/13/2022BarclaysLower Target$120.00
7/12/2022The Goldman Sachs GroupInitiated CoverageNeutral$260.00
5/11/2022CitigroupBoost Target$240.00 ➝ $260.00
2/18/2022CitigroupLower Target$280.00 ➝ $240.00
12/20/2021CitigroupLower TargetBuy$360.00 ➝ $280.00
11/11/2021BarclaysLower TargetEqual Weight$280.00 ➝ $240.00
10/4/2021CitigroupInitiated CoverageBuy$360.00
8/20/2021Tigress FinancialInitiated CoverageBuy$360.00
4/7/2021B. RileyInitiated CoverageBuy$400.00
3/19/2021BarclaysInitiated CoverageEqual Weight$280.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.74 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/9/2025
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/8/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/7/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/6/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/6/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/5/2025
  • 12 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/5/2025

Current Sentiment

  • 12 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Claritev logo
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
Read More

Today's Range

Now: $36.77
Low: $36.45
High: $40.51

50 Day Range

MA: $54.97
Low: $36.77
High: $71.36

52 Week Range

Now: $36.77
Low: $5.61
High: $74.07

Volume

199,937 shs

Average Volume

263,456 shs

Market Capitalization

$607.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52

Frequently Asked Questions

What sell-side analysts currently cover shares of Claritev?

The following Wall Street research analysts have issued stock ratings on Claritev in the last twelve months: Citigroup Inc., and Weiss Ratings.
View the latest analyst ratings for CTEV.

What is the current price target for Claritev?

0 Wall Street analysts have set twelve-month price targets for Claritev in the last year. Their average twelve-month price target is $80.00, suggesting a possible upside of 117.6%. Citigroup Inc. has the highest price target set, predicting CTEV will reach $80.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $80.00 for Claritev in the next year.
View the latest price targets for CTEV.

What is the current consensus analyst rating for Claritev?

Claritev currently has 1 sell rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CTEV, but not buy more shares or sell existing shares.
View the latest ratings for CTEV.

What other companies compete with Claritev?

Other companies that are similar to Claritev include PagSeguro Digital, CarGurus, JOYY, JOYY and Xometry. Learn More about companies similar to Claritev.

How do I contact Claritev's investor relations team?

The company's listed phone number is 1-800-677-1098 and its investor relations email address is [email protected]. The official website for Claritev is www.claritev.com. Learn More about contacing Claritev investor relations.